Coya TherapeuticsCOYA
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 19 institutions reported holding Coya Therapeutics Inc. (COYA) in their 13F filings, unchanged from Q2 2024. 2 opened new positions and 2 sold out. The largest holders were Greenlight Capital (DME Capital Management) ($8.2M), Vanguard Group Inc. ($5.5M) and AIGH Capital Management LLC ($4.2M). 2 famous investors held it, including David Einhorn (0.3% of Greenlight Capital (DME Capital Management)'s portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Coya Therapeutics Inc.
- CUSIP
- 22407B108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $210K |
| Exits | 2 | $125K |
All 13F filers, Q2 2024 → Q3 2024: 81,265 shares bought and 35,644 shares sold, net +45,621 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Greenlight Capital (DME Capital Management) | 0.34% | No change | 1,274,026 | $8.2M |
| Vanguard Group Inc. | 0.00% | No change | 845,424 | $5.5M |
| AIGH Capital Management LLC | 1.96% | No change | 649,427 | $4.2M |
| CM Management, LLC | 0.74% | Add +44.1% | 144,059 | $929K |
| Geode Capital Management, LLC | 0.00% | Add +3.3% | 142,309 | $918K |
| BlackRock, Inc. | 0.00% | — | 65,826 | $425K |
| State Street Corp. | 0.00% | No change | 43,000 | $277K |
| Prelude Capital Management, LLC | 0.02% | No change | 35,770 | $231K |
| GHP Investment Advisors, Inc. | 0.01% | New | 26,171 | $169K |
| Northern Trust Corp. | 0.00% | No change | 25,450 | $164K |
| Royal Bank of Canada | 0.00% | Reduce -32.0% | 22,902 | $148K |
| Renaissance Technologies | 0.00% | Add +3.0% | 17,200 | $111K |
| Mirador Capital Partners LP | 0.02% | Reduce -3.2% | 14,261 | $92K |
| Jones Financial Companies LLLP | 0.00% | New | 6,050 | $41K |
| Osaic Holdings, Inc. | 0.00% | Reduce -43.9% | 1,874 | $12K |
| Morgan Stanley | 0.00% | No change | 800 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -82.3% | 475 | $3K |
| Bank of America Corp. | 0.00% | Reduce -0.9% | 106 | $684 |
| JPMorgan Chase & Co. | 0.00% | Reduce -3.1% | 31 | $200 |
"% of holder's portfolio" is COYA's weight in each manager's 13F, not the share of Coya Therapeutics Inc. the manager owns.